Risk Factors and Treatment at Recurrent Stroke Onset: Results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study

Publisher： Karger

E-ISSN： 1421-9786|25|3|254-260

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.25, Iss.3, 2008-01, pp. : 254-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discontinuation of Antiplatelet Study Medication and Risk of Recurrent Stroke and Cardiovascular Events: Results from the PRoFESS Study

By  

Cerebrovascular Diseases, Vol. 35, Iss. 6, 2013-06 ,pp. : 538-543

Karger

Access to resources Recommend Favorite

Perception of Recurrent Stroke Risk among Stroke Survivors

By  

Neuroepidemiology, Vol. 37, Iss. 2, 2011-09 ,pp. : 88-89

Karger

Access to resources Recommend Favorite

Discontinuation of Antiplatelet Treatment and Risk of Recurrent Stroke and All-Cause Death: A Cohort Study

By  

Neuroepidemiology, Vol. 43, Iss. 1, 2014-10 ,pp. : 57-64

Karger

Access to resources Recommend Favorite

Comparison of Warfarin versus Aspirin for the Prevention of Recurrent Stroke or Death: Subgroup Analyses from the Warfarin-Aspirin Recurrent Stroke Study

By  

Cerebrovascular Diseases, Vol. 22, Iss. 1, 2006-04 ,pp. : 4-12

Karger

Access to resources Recommend Favorite

Trends in Five-Year Survival and Risk of Recurrent Stroke after First-Ever Stroke in the Perth Community Stroke Study

By  

Cerebrovascular Diseases, Vol. 19, Iss. 3, 2005-03 ,pp. : 179-185

Karger

Access to resources Recommend Favorite